Fracture's President Gilles Renevier poses next to the entrance of the future construction site of a logistics center ordered by Goodman real estate, in Colombier-Saugnieu, near Lyon Saint-Exupery airport, France, June 11, 2020. Picture taken June 11, 2020. REUTERS/Christian Hartmann

Fracture's President Gilles Renevier poses next to the entrance of the future construction site of a logistics center ordered by Goodman real estate, in Colombier-Saugnieu, near Lyon Saint-Exupery airport, France, June 11, 2020. Picture taken June 11, 2020. REUTERS/Christian Hartmann

Fracture's President Gilles Renevier poses next to the entrance of the future construction site of a logistics center ordered by Goodman real estate, in Colombier-Saugnieu, near Lyon Saint-Exupery airport, France, June 11, 2020. Picture taken June 11, 2020. REUTERS/Christian Hartmann

A general view shows the future construction site of a logistics center ordered by Goodman real estate, in Colombier-Saugnieu, near Lyon Saint-Exupery airport, France, June 11, 2020. Picture taken June 11, 2020. REUTERS/Christian Hartmann

A general view shows the future construction site of a logistics center ordered by Goodman real estate, in Colombier-Saugnieu, near Lyon Saint-Exupery airport, France, June 11, 2020. Picture taken June 11, 2020. REUTERS/Christian Hartmann

A building permit sign is seen next to the entrance of the future construction site of a logistics center ordered by Goodman real estate, in Colombier-Saugnieu, near Lyon Saint-Exupery airport, France, June 11, 2020. Picture taken June 11, 2020. REUTERS/Christian Hartmann

A camera is seen next to the entrance of the future construction site of a logistics center ordered by Goodman real estate, in Colombier-Saugnieu, near Lyon Saint-Exupery airport, France, June 11, 2020. Picture taken June 11, 2020. REUTERS/Christian Hartmann

A building permit sign is seen next to the entrance of the future construction site of a logistics center ordered by Goodman real estate, in Colombier-Saugnieu, near Lyon Saint-Exupery airport, France, June 11, 2020. Picture taken June 11, 2020. REUTERS/Christian Hartmann

A general view shows the future construction site of a logistics center ordered by Goodman real estate, in Colombier-Saugnieu, near Lyon Saint-Exupery airport, France, June 11, 2020. Picture taken June 11, 2020. REUTERS/Christian Hartmann

Fracture's President Gilles Renevier poses next to the entrance of the future construction site of a logistics center ordered by Goodman real estate, in Colombier-Saugnieu, near Lyon Saint-Exupery airport, France, June 11, 2020. Picture taken June 11, 2020. REUTERS/Christian Hartmann

French President Emmanuel Macron gestures as he delivers a speech at French drugmaker's vaccine unit Sanofi Pasteur plant, in Marcy-l'Etoile, near Lyon, France June 16, 2020. Laurent Cipriani/Pool via REUTERS

French President Emmanuel Macron gestures as he delivers a speech at French drugmaker's vaccine unit Sanofi Pasteur plant, in Marcy-l'Etoile, near Lyon, France June 16, 2020. Laurent Cipriani/Pool via REUTERS

French President Emmanuel Macron gestures as he delivers a speech at French drugmaker's vaccine unit Sanofi Pasteur plant, in Marcy-l'Etoile, near Lyon, France June 16, 2020. Laurent Cipriani/Pool via REUTERS

French President Emmanuel Macron reacts after delivering a speech at French drugmaker's vaccine unit Sanofi Pasteur plant, in Marcy-l'Etoile, near Lyon, France June 16, 2020. Laurent Cipriani/Pool via REUTERS

French President Emmanuel Macron answers questions from journalists after his speech during a visit at the French drugmaker's vaccine unit Sanofi Pasteur plant in Marcy-l'Etoile, near Lyon, France, June 16, 2020. REUTERS/Gonzalo Fuentes/Pool

French President Emmanuel Macron answers questions from journalists after his speech during a visit at the French drugmaker's vaccine unit Sanofi Pasteur plant in Marcy-l'Etoile, near Lyon, France, June 16, 2020. REUTERS/Gonzalo Fuentes/Pool

CEO of Sanofi Paul Hudson delivers a speech at the industrial development laboratory at French drugmaker's vaccine unit Sanofi Pasteur plant, in Marcy-l'Etoile, near Lyon, France June 16, 2020. Laurent Cipriani/Pool via REUTERS

French President Emmanuel Macron delivers a speech after a visit at the French drugmaker's vaccine unit Sanofi Pasteur plant in Marcy-l'Etoile, near Lyon, France, June 16, 2020. REUTERS/Gonzalo Fuentes/Pool

French President Emmanuel Macron delivers a speech after a visit at the French drugmaker's vaccine unit Sanofi Pasteur plant in Marcy-l'Etoile, near Lyon, France, June 16, 2020. REUTERS/Gonzalo Fuentes/Pool

French President Emmanuel Macron delivers a speech after a visit at the French drugmaker's vaccine unit Sanofi Pasteur plant in Marcy-l'Etoile, near Lyon, France, June 16, 2020. REUTERS/Gonzalo Fuentes/Pool

French President Emmanuel Macron delivers a speech after a visit at the French drugmaker's vaccine unit Sanofi Pasteur plant in Marcy-l'Etoile, near Lyon, France, June 16, 2020. REUTERS/Gonzalo Fuentes/Pool

French President Emmanuel Macron delivers a speech after a visit at the French drugmaker's vaccine unit Sanofi Pasteur plant in Marcy-l'Etoile, near Lyon, France, June 16, 2020. REUTERS/Gonzalo Fuentes/Pool

French President Emmanuel Macron and Paul Hudson, Chief Executive Officer of Sanofi, arrive to deliver speeches after a visit at the French drugmaker's vaccine unit Sanofi Pasteur plant in Marcy-l'Etoile, near Lyon, France, June 16, 2020. REUTERS/Gonzalo Fuentes/Pool

French President Emmanuel Macron and Paul Hudson, Chief Executive Officer of Sanofi, arrive to deliver speeches after a visit at the French drugmaker's vaccine unit Sanofi Pasteur plant in Marcy-l'Etoile, near Lyon, France, June 16, 2020. REUTERS/Gonzalo Fuentes/Pool

French President Emmanuel Macron listens to a researcher as he visits an industrial development laboratory at French drugmaker's vaccine unit Sanofi Pasteur plant, in Marcy-l'Etoile, near Lyon, France June 16, 2020. Laurent Cipriani/Pool via REUTERS TPX IMAGES OF THE DAY

French President Emmanuel Macron listens to a researcher as he visits an industrial development laboratory at French drugmaker's vaccine unit Sanofi Pasteur plant, in Marcy-l'Etoile, near Lyon, France June 16, 2020. Laurent Cipriani/Pool via REUTERS

French President Emmanuel Macron listens to researchers as he visits an industrial development laboratory at French drugmaker's vaccine unit Sanofi Pasteur plant, in Marcy-l'Etoile, near Lyon, France June 16, 2020. Laurent Cipriani/Pool via REUTERS

Paul Hudson, Chief Executive Officer of Sanofi, delivers a speech after a visit at the French drugmaker's vaccine unit Sanofi Pasteur plant in Marcy-l'Etoile, near Lyon, France, June 16, 2020. REUTERS/Gonzalo Fuentes/Pool

Paul Hudson, Chief Executive Officer of Sanofi, delivers a speech after a visit at the French drugmaker's vaccine unit Sanofi Pasteur plant in Marcy-l'Etoile, near Lyon, France, June 16, 2020. REUTERS/Gonzalo Fuentes/Pool

French President Emmanuel Macron speaks to a group of researchers as he visits an industrial development laboratory at French drugmaker's vaccine unit Sanofi Pasteur plant, in Marcy-l'Etoile, near Lyon, France June 16, 2020. Laurent Cipriani/Pool via REUTERS

French President Emmanuel Macron listens to a researcher as he visits an industrial development laboratory at French drugmaker's vaccine unit Sanofi Pasteur plant, in Marcy-l'Etoile, near Lyon, France June 16, 2020. Laurent Cipriani/Pool via REUTERS

French President Emmanuel Macron listens to a researcher as he visits an industrial development laboratory at French drugmaker's vaccine unit Sanofi Pasteur plant, in Marcy-l'Etoile, near Lyon, France June 16, 2020. Laurent Cipriani/Pool via REUTERS

French President Emmanuel Macron visits an industrial development laboratory at French drugmaker's vaccine unit Sanofi Pasteur plant, in Marcy-l'Etoile, near Lyon, France June 16, 2020. Laurent Cipriani/Pool via REUTERS

Board Director of Sanofi Serge Weinberg, French President Emmanuel Macron, CEO of Sanofi Paul Hudson and President of Sanofi France Olivier Bogillot arrive at the French drugmaker's vaccine unit Sanofi Pasteur plant in Marcy-l'Etoile, near Lyon, France June 16, 2020. Laurent Cipriani/Pool via REUTERS

Board Director of Sanofi Serge Weinberg, CEO of Sanofi Paul Hudson, President of Sanofi France Olivier Bogillot and French President Emmanuel Macron arrive at the French drugmaker's vaccine unit Sanofi Pasteur plant in Marcy-l'Etoile, near Lyon, France June 16, 2020. Laurent Cipriani/Pool via REUTERS

Board Director of Sanofi Serge Weinberg, CEO of Sanofi Paul Hudson, French President Emmanuel Macron and President of Sanofi France Olivier Bogillot pose for a group photo at the French drugmaker's vaccine unit Sanofi Pasteur plant in Marcy-l'Etoile, near Lyon, France June 16, 2020. Laurent Cipriani/Pool via REUTERS

French President Emmanuel Macron, wearing a protective face mask, visits an industrial development laboratory at the French drugmaker's vaccine unit Sanofi Pasteur plant in Marcy-l'Etoile, near Lyon, France, June 16, 2020. REUTERS/Gonzalo Fuentes/Pool

French President Emmanuel Macron adjusts his protective face mask as he visits an industrial development laboratory at the French drugmaker's vaccine unit Sanofi Pasteur plant in Marcy-l'Etoile, near Lyon, France, June 16, 2020. REUTERS/Gonzalo Fuentes/Pool

French President Emmanuel Macron, wearing a protective face mask, visits an industrial development laboratory at the French drugmaker's vaccine unit Sanofi Pasteur plant in Marcy-l'Etoile, near Lyon, France, June 16, 2020. REUTERS/Gonzalo Fuentes/Pool

French President Emmanuel Macron, wearing a protective face mask, visits an industrial development laboratory at the French drugmaker's vaccine unit Sanofi Pasteur plant in Marcy-l'Etoile, near Lyon, France, June 16, 2020. REUTERS/Gonzalo Fuentes/Pool

French President Emmanuel Macron, wearing a protective face mask, visits an industrial development laboratory at the French drugmaker's vaccine unit Sanofi Pasteur plant in Marcy-l'Etoile, near Lyon, France, June 16, 2020. REUTERS/Gonzalo Fuentes/Pool

French President Emmanuel Macron, wearing a protective face mask, gestures as he visits an industrial development laboratory at the French drugmaker's vaccine unit Sanofi Pasteur plant in Marcy-l'Etoile, near Lyon, France, June 16, 2020. REUTERS/Gonzalo Fuentes/Pool

French President Emmanuel Macron, Thomas Triomphe, Executive Vice President of Sanofi Pasteur, and Paul Hudson, Chief Executive Officer of Sanofi, wearing protective face masks, visit an industrial development laboratory at the French drugmaker's vaccine unit Sanofi Pasteur plant in Marcy-l'Etoile, near Lyon, France, June 16, 2020. REUTERS/Gonzalo Fuentes/Pool

French President Emmanuel Macron adjusts his protective face mask as he visits an industrial development laboratory at the French drugmaker's vaccine unit Sanofi Pasteur plant in Marcy-l'Etoile, near Lyon, France, June 16, 2020. REUTERS/Gonzalo Fuentes/Pool

French President Emmanuel Macron, wearing a protective face mask, visits an industrial development laboratory at the French drugmaker's vaccine unit Sanofi Pasteur plant in Marcy-l'Etoile, near Lyon, France, June 16, 2020. REUTERS/Gonzalo Fuentes/Pool

French President Emmanuel Macron, wearing a protective face mask, talks with researchers as he visits an industrial development laboratory at the French drugmaker's vaccine unit Sanofi Pasteur plant in Marcy-l'Etoile, near Lyon, France, June 16, 2020. REUTERS/Gonzalo Fuentes/Pool

French President Emmanuel Macron, wearing a protective face mask, salutes researchers as he visits an industrial development laboratory at the French drugmaker's vaccine unit Sanofi Pasteur plant in Marcy-l'Etoile, near Lyon, France, June 16, 2020. REUTERS/Gonzalo Fuentes/Pool

French President Emmanuel Macron, wearing a protective face mask, talks with researchers as he visits an industrial development laboratory at the French drugmaker's vaccine unit Sanofi Pasteur plant in Marcy-l'Etoile, near Lyon, France, June 16, 2020. REUTERS/Gonzalo Fuentes/Pool

French President Emmanuel Macron, wearing a protective face mask, salutes researchers as he visits an industrial development laboratory at the French drugmaker's vaccine unit Sanofi Pasteur plant in Marcy-l'Etoile, near Lyon, France, June 16, 2020. REUTERS/Gonzalo Fuentes/Pool

French President Emmanuel Macron, wearing a protective face mask, visits an industrial development laboratory at the French drugmaker's vaccine unit Sanofi Pasteur plant in Marcy-l'Etoile, near Lyon, France, June 16, 2020. REUTERS/Gonzalo Fuentes/Pool

French President Emmanuel Macron, wearing a protective face mask, talks with researchers as he visits an industrial development laboratory at the French drugmaker's vaccine unit Sanofi Pasteur plant in Marcy-l'Etoile, near Lyon, France, June 16, 2020. REUTERS/Gonzalo Fuentes/Pool

French President Emmanuel Macron, wearing a protective face mask, visits an industrial development laboratory at the French drugmaker's vaccine unit Sanofi Pasteur plant in Marcy-l'Etoile, near Lyon, France, June 16, 2020. REUTERS/Gonzalo Fuentes/Pool

French President Emmanuel Macron, wearing a protective face mask, listens to researchers as he visits an industrial development laboratory at the French drugmaker's vaccine unit Sanofi Pasteur plant in Marcy-l'Etoile, near Lyon, France, June 16, 2020. REUTERS/Gonzalo Fuentes/Pool

The hands of French President Emmanuel Macron are pictured as he visits an industrial development laboratory at the French drugmaker's vaccine unit Sanofi Pasteur plant in Marcy-l'Etoile, near Lyon, France, June 16, 2020. REUTERS/Gonzalo Fuentes/Pool

French President Emmanuel Macron, wearing a protective face mask, visits an industrial development laboratory at the French drugmaker's vaccine unit Sanofi Pasteur plant in Marcy-l'Etoile, near Lyon, France, June 16, 2020. REUTERS/Gonzalo Fuentes/Pool

French President Emmanuel Macron, wearing a protective face mask, visits an industrial development laboratory at the French drugmaker's vaccine unit Sanofi Pasteur plant in Marcy-l'Etoile, near Lyon, France, June 16, 2020. REUTERS/Gonzalo Fuentes/Pool

French President Emmanuel Macron, wearing a protective face mask, listens to researchers as he visits an industrial development laboratory at the French drugmaker's vaccine unit Sanofi Pasteur plant in Marcy-l'Etoile, near Lyon, France, June 16, 2020. REUTERS/Gonzalo Fuentes/Pool

French President Emmanuel Macron, Thomas Triomphe, Executive Vice President of Sanofi Pasteur, and Paul Hudson, Chief Executive Officer of Sanofi, wearing protective face masks, visit an industrial development laboratory at the French drugmaker's vaccine unit Sanofi Pasteur plant in Marcy-l'Etoile, near Lyon, France, June 16, 2020. REUTERS/Gonzalo Fuentes/Pool

French President Emmanuel Macron, Thomas Triomphe, Executive Vice President of Sanofi Pasteur, and Paul Hudson, Chief Executive Officer of Sanofi, wearing protective face masks, visit an industrial development laboratory at the French drugmaker's vaccine unit Sanofi Pasteur plant in Marcy-l'Etoile, near Lyon, France, June 16, 2020. REUTERS/Gonzalo Fuentes/Pool

French President Emmanuel Macron, wearing a protective face mask, listens to researchers as he visits an industrial development laboratory at the French drugmaker's vaccine unit Sanofi Pasteur plant in Marcy-l'Etoile, near Lyon, France, June 16, 2020. REUTERS/Gonzalo Fuentes/Pool